On‐treatment gamma‐glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients

enthalten in: Liver International | 2022

von Huang, C. | Jang, T. | Jun, D. | +22

Is ageing a problematic hurdle to the efficacy of first‐line atezolizumab plus bevacizumab in hepatocellular carcinoma?

enthalten in: Liver International | 2022

von An, J. | Shim, J.

Clinicopathological and molecular characterization of chromophobe hepatocellular carcinoma

enthalten in: Liver International | 2021

von Kang, H. | Oh, J. | Kim, Y. | +9